T1	Participants 250 296	in patients with obstructive sleep apnea (OSA)
T2	Participants 508 548	Patients were admitted to the laboratory
T3	Participants 784 829	patients received 200 mg modafinil or placebo
T4	Participants 579 640	CPAP was used for the first night, followed by a baseline day
T5	Participants 784 886	patients received 200 mg modafinil or placebo (n = 21) in a randomized, double-blind, crossover design
